Kingfisher Capital LLC Cooper Companies, Inc. Transaction History

Kingfisher Capital LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 10, 2022	SELL	$379.46 - $424.54 $2.34 Million - $2.61 Million	-6,155 Closed	0 $0
Q4 2021 Jan 25, 2022	BUY	$373.53 - $434.12 $153,147 - $177,989	410 Added 7.14%	6,155 $2.58 Million
Q3 2021 Oct 29, 2021	BUY	$396.76 - $455.92 $69,433 - $79,786	175 Added 3.14%	5,745 $2.37 Million
Q2 2021 Aug 03, 2021	BUY	$372.36 - $412.07 $76,706 - $84,886	206 Added 3.84%	5,570 $2.21 Million
Q1 2021 May 07, 2021	BUY	$357.26 - $392.57 $120,396 - $132,296	337 Added 6.7%	5,364 $2.06 Million
Q4 2020 Jan 28, 2021	BUY	$319.05 - $363.32 $107,838 - $122,802	338 Added 7.21%	5,027 $1.83 Million
Q3 2020 Nov 12, 2020	BUY	$280.08 - $347.78 $1.31 Million - $1.63 Million	4,689 New	4,689 $1.58 Million

1.59M

Ticker COO
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 49,346,000
Market Cap $4.72B
Description
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...

Get notified when there are updates to the investment portfolio of Kingfisher Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Kingfisher Capital LLC with notifications on news.